Evidence map›Paper›PMID 38017111›Full record

ArticleScientific reports2023

Enhanced production of a recombinant xylanase (XT6): optimization of production and purification, and scaled-up batch fermentation in a stirred tank bioreactor.

Priyashini Dhaver, Tariro Sithole, Brett Pletschke, Bruce Sithole, Roshini Govinden

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Endo-β-1,4-Xylanase GH10 fromInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Priyashini DhaverDiscipline of Microbiology, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa.
Tariro SitholeEnzyme Science Programme (ESP), Department of Biochemistry and Microbiology, Rhodes University, Makhanda (Grahamstown), 6140, Eastern Cape, South Africa.
Brett PletschkeEnzyme Science Programme (ESP), Department of Biochemistry and Microbiology, Rhodes University, Makhanda (Grahamstown), 6140, Eastern Cape, South Africa. b.pletschke@ru.ac.za.
Bruce SitholeBiorefinery Industry Development Facility, Council for Scientific and Industrial Research, Durban, 4000, South Africa.
Roshini GovindenDiscipline of Microbiology, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa.
University of KwaZulu-Natal · ZARhodes University · ZA

Funding

TIA-managed SIIP grant and Rhodes University (2018/FUN/0180)TIA SIIP: ENZYME AND MICROBIAL TECHNOLOGIES (EMT) grant and University of KwaZulu-Natal-Natal DST/CON/0177/2018
6 · The paper itself

Abstract

The endoxylanase XT6 produced by Geobacillus stearothermophilus is a desirable candidate for industrial applications. In this study, the gene encoding XT6 was cloned using the pET-28a expression vector and expressed in Escherichia coli BL21 (DE3) cells. Recombinant XT6 production was improved by optimizing cell lysis (sonication, chemical, and enzymatic lysis) and expression conditions. Sonication in a 0.05 M sodium phosphate (pH 6.0) buffer resulted in the highest xylanase activity (16.48 U/ml). Screening and optimization of induction conditions using the Plackett-Burman Design and Box-Behnken Design (BBD) approaches revealed that cell density pre-induction (OD

Indexed as

BioreactorsEscherichia coliEndo-1,4-beta XylanasesFermentationRecombinant ProteinsEndo-1,4-beta XylanasesRecombinant Proteins

Identifiers

PMID38017111
PMCPMC10684889
OpenAlexW4389087641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.